Request for Information - Radiopharmaceuticals for Naval Medical Center Portsmouth, VA, Naval Medical Center Camp Lejeune, NC, and Naval Health Clinic Jacksonville, FL
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency (DHA) is conducting a Request for Information (RFI) to identify potential sources for Radiopharmaceuticals for three Medical Treatment Facilities (MTFs): Naval Medical Center Portsmouth, VA; Naval Medical Center Camp Lejeune, NC; and Naval Health Clinic Jacksonville, FL. This RFI aims to gather information for a future Indefinite Delivery, Indefinite Quantity (IDIQ) Firm Fixed Price (FFP) contract. Responses are due April 26, 2026.
Purpose & Background
This RFI is for planning purposes only and does not constitute a solicitation. The DHA seeks to identify capable vendors and determine the commercial nature of required radiopharmaceutical supplies. The current contracts for these services expire on September 30, 2026, necessitating a new IDIQ contract to ensure continuous supply to the MTF Radiology Departments.
Scope of Work
The future contract will require the provision of all personnel, equipment, supplies, and services necessary for the delivery of unit dose radiopharmaceuticals on an as-needed basis. Key requirements, as detailed in the DRAFT Statement of Work (SOW), include:
- Preparation according to manufacturer specifications, with strict adherence to purity testing and calibration time accuracy (e.g., +/- 10% for diagnostic, +/- 5% for therapeutic doses).
- Proper labeling of all doses and containers.
- Compliance with all applicable National Regulatory Commission (NRC) and Department of Transportation (DOT) regulations, as well as facility-specific Radiation Safety Committee policies and Navy Radioactive Materials Permits.
- Performance standards include a 95% on-time delivery rate and 2-hour delivery for emergent orders.
Contract Details
- Anticipated Contract Type: Indefinite Delivery, Indefinite Quantity (IDIQ) Firm Fixed Price (FFP).
- NAICS: 325412 Pharmaceutical Preparation Manufacturing.
- PSC: 6505 Drugs and Biologicals.
- Anticipated Ordering Period: October 1, 2026 – September 30, 2031.
- Set-Aside: None specified (this is an RFI).
Submission Requirements
Interested parties should submit a capabilities statement electronically in Microsoft Word or Adobe PDF format. The submission must include a cover page with organizational details and points of contact, and address:
- Clear understanding and ability to perform the scope as detailed in the DRAFT SOW.
- Experience performing similar work.
- Existing contract vehicles (e.g., GSA schedule).
- Whether services are provided to the general public under similar terms.
Key Dates & Contact
- Responses Due: Sunday, April 26, 2026, by 5:00 PM EST.
- Submission To: Ms. Carol Uebelacker, carol.e.uebelacker.civ@health.mil.
- Published: April 11, 2026.
Additional Notes
This is strictly an RFI; no solicitation exists, and no phone calls will be accepted. Responders are responsible for all associated expenses. Proprietary information will be handled accordingly.